In This Article:
Winnipeg, Manitoba--(Newsfile Corp. - November 29, 2022) - Novra Technologies Inc. (TSXV: NVI) ("Novra") has announced its financial results for the nine months ended September 30, 2022. All amounts are in Canadian dollars unless otherwise noted.
Novra is pleased to announce Q3 revenue of $2.1 million (2021: $891 thousand) and Net Income of $14 thousand (2021: loss of $694 thousand), which is a continuation of the improvements in our financial results that began in Q2. While our full nine-month Net Income has not yet recovered from the revenue slow-down in Q1, which was significantly impacted by the geo-political and public health situations that continue to effect global supply chains, Adjusted EBITDA(2) for the full period moved positive.
Consolidated Financial Results for Q3 and the First Nine Months of 2022
At $2.1 million, Q3 revenue improved significantly over the same period in 2021. For the nine-month period, revenue was $5.4 million compared to $5.7 million in 2021 and Net Income was a loss of $836 thousand compared to loss of $47 thousand in 2021. This large difference in Net Income on similar revenue was the result of last year's $1.0 million income from government support programs related to COVID-19, which were provided in 2021, but largely phased out by 2022.
Adjusted EBITDA for the nine-month period was $187 thousand. This measure also trended up this quarter, both compared to the prior quarter and to the same quarter in 2021. In the current quarter Adjusted EBITDA was $318 thousand, compared to negative $380 thousand in the same quarter in 2021, which is an improvement of almost $700 thousand.
(In Thousands) |
| Three Months Ended September 30, | | | Period ended September 30, |
| ||||||||||||
| | 2022 | | | 2021 | | | % Chg | | | 2022 | | | 2021 | | | % Chg |
|
Revenue by type: | | | | | | | | | | | | | | | | | | |
Products | $ | 1,809 | | $ | 535 | | | 238% | | $ | 4,267 | | $ | 4,581 | | | -7% | |
Services | | 332 | | | 356 | | | -7% | | | 1,141 | | | 1,116 | | | 2% |
|
Total revenue | | 2,141 | | | 891 | | | 140% | | | 5,408 | | | 5,697 | | | -5% |
|
| |
| | |
| | |
| | |
| | |
| | |
| |
Gross profit | | 999 | | | 193 | | | 419% | | | 2,517 | | | 2,760 | | | -9% | |
Gross margin | | 46.7% | | | 21.6% | | |
| | | 46.5% | | | 48.5% | | |
| |
Operating expenses | | 1,008 | | | 1,185 | | | -15% | | | 3,319 | | | 3,720 | | | -11% |
|
Operating income (loss) | | (9 | ) | | (992 | ) | | -99% | | | (802 | ) | | (960 | ) | | -16% |
|
Other income (expenses) | | 23 | | | 298 | | | -92% | | | (34 | ) | | 912 | | | NM |
|
Net income (loss) as reported under IFRS | $ | 14 | | $ | (694 | ) | | NM | | $ | (836 | ) | $ | (47 | ) | | 1669% |
|
| |
| | |
| | |
| | |
| | |
| | |
|
|
Adjusted EBITDA - non-IFRS measure(2) | $ | 318 | | $ | (380 | ) | | NM | | $ | 187 | | $ | 900 | | | -79% |
|
NM - Not meaningful |
On September 30, 2022, Novra's deferred revenue and bookings backlog totalled more than $4.2 million and substantial additional bookings have been added in Q4. This provides some visibility into future revenues. However, due to continuing global geopolitical and public health situations coupled with high inflation and rising interest rates, we expect volatility in our revenue and income to continue over the next several quarters as these impact our clients and the economy in general.